Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
03/2003
03/18/2003US6534627 Synthesis and use of amino acid fluorides as peptide coupling reagents
03/18/2003US6534530 Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors
03/18/2003US6534499 For therapy of autoimmune disease
03/18/2003CA2422709A1 Substituted cinnamic acid guanidides, method for the production thereof,their use as a medicament, and to a medicament containing these compounds
03/18/2003CA2362944C Optical isomers of ¬3-(1,1-dialkylated)-1-aminomethyl-pyrrolidine|
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/13/2003WO2004043335A2 Methods of treating infection by drug resistant bacteria
03/13/2003WO2003022007A1 Organic light emitting devices having carrier blocking layers comprising metal complexes
03/13/2003WO2003020684A1 (alpha)-haloenamine reagents
03/13/2003WO2003020029A1 Arylamines as inhibitors of chemokine binding to us28
03/13/2003WO2003004472A8 Arylamines for the treatment of conditions associated with gsk-3
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002072506A3 7-pyrollyl tetracycline compounds and methods of use thereof
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003WO2002024194A3 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/13/2003US20030050310 Hydroxamic acid derivatives as proteinase inhibitors
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030050297 Administering to a mammal, a low molecular weight antioxidants, mimetics of superoxide dismutase
03/13/2003CA2458926A1 Methods of treating infection by drug resistant bacteria
03/13/2003CA2458859A1 (alpha)-haloenamine reagents
03/12/2003EP1291081A1 Process for the preparation of pyrrole and pyridine
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289954A1 Serine protease inhibitors
03/12/2003EP1289953A1 Serine protease inhibitors
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003EP0858335B1 2-alkylpyrrolidines
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402706A Antidiabetic agents
03/12/2003CN1402637A Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531594 Process for producing 1H-3-aminopyrrolidine and derivatives thereof
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531452 Peptide-like and peptidomimetic compounds that inhibit enzymatic activity of picornaviral 3C proteases and inhibit picornavirus replication
03/11/2003US6531424 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
03/06/2003WO2003018854A2 Immobilization of biological molecules onto surfaces coated with monolayers
03/06/2003WO2003018583A1 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
03/06/2003WO2003018554A1 3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase
03/06/2003WO2003018553A1 Oral antidiabetic agents
03/06/2003WO2003018552A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/06/2003WO2003018551A1 New mandelic acid derivatives and their use as thrombin inhibitors
03/06/2003WO2003018549A2 Bicyclic compounds as inhibitors of chemokine binding to us28
03/06/2003WO2003018547A2 An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
03/06/2003WO2003018536A1 Chemotherapeutic agents
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2003018005A1 use of nefiracetam for treating neurodegeneration
03/06/2003WO2003018004A2 Analgetic pyrroline derivatives
03/06/2003WO2003000198A3 Selective neuronal nitric oxide synthase inhibitors
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002070470A3 Benzophenones as inhibitors of reverse transcriptase
03/06/2003WO2002000650A9 Novel compounds possessing antibacterial, antifungal or antitumor activity
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045726 Novel immunotherapeutic agents
03/06/2003US20030045712 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use therof as pharmaceutical compositions
03/06/2003US20030045581 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/06/2003US20030045579 Compounds and compositions for delivering active agents
03/06/2003US20030045479 Novel N-formyl hydroxylamine compounds, compositions and methods of use
03/06/2003US20030045461 Composition and methods of esterified nitroxides gated with carboxylic acids
03/06/2003US20030045432 Phenyl-substituted cyclic ketoenols
03/06/2003CA2458844A1 Immobilization of biological molecules onto surfaces coated with monolayers
03/06/2003CA2458621A1 Oral antidiabetic agents
03/06/2003CA2458616A1 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/06/2003CA2458015A1 Analgetic pyrroline derivatives
03/06/2003CA2457676A1 Chemotherapeutic agents
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288201A1 Optically active maleimide derivatives, optically active polymaleimide derivatives, production method thereof, separating agent using the same derivative, and method for separating optically active compounds using the same agent
03/05/2003EP1288198A1 Process for the production of sulfonic esters
03/05/2003EP1287821A1 Multiparticulate formulations of atorvastatin calcium having a modulated rate of drug release
03/05/2003EP1287404A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0942901B1 Cyclic imines as pesticides
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/04/2003US6528678 Phosgene-free process for preparing carbamates
03/04/2003US6528661 Providing atorvastatin ester derivative; converting the atorvastatin ester derivative to atorvastatin hemi-calcium with calcium hydroxide
03/04/2003US6528660 Process for the production of amorphous atorvastatin calcium
03/04/2003US6528659 Condensation between protected and unprotected pyrroles to form chemical intermediates; deprotecting; easier purifi-cation, isolation, storage and transportation
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
03/04/2003US6528647 Process for the synthesis of an aliphatic cyclic amine
03/04/2003US6528510 HIV protease inhibitors
03/04/2003US6528503 Anticoagulants
03/04/2003CA2400565A1 Biomodulated multiparticulate formulations
03/04/2003CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists
02/2003
02/27/2003WO2003016317A1 Processes for preparing calcium salt forms of statins
02/27/2003WO2003016284A1 Substituted anthranilamides for controlling invertebrate pests
02/27/2003WO2003016275A1 Antiviral agent
02/27/2003WO2003016273A2 Peptide arginals and methods for treating disseminated intravascular coagulation
02/27/2003WO2002096398A3 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for treating diabetes mellitus
02/27/2003WO2002074050A3 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor
02/27/2003WO2002057422A3 Ternary biomolecule/polymer/surface-based immobilization systems
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 404